New drug aims to protect transplanted kidneys
NCT ID NCT04837092
First seen Jan 17, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tested a new drug called FR104 in 10 people receiving a kidney transplant for the first time. The goal was to see if FR104 is safe and can help prevent the body from rejecting the new kidney. Researchers monitored side effects and kidney function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blancho
Nantes, France
Conditions
Explore the condition pages connected to this study.